HRAS1 Variable Number of Tandem Repeats Polymorphism in Japanese Patients with Colorectal Adenoma and Cancer by Miura, Masahiko et al.
Yonago Acta medica 2006;49:1–7   
1
HRAS1 Variable Number of Tandem Repeats Polymorphism 
in Japanese Patients with Colorectal Adenoma and Cancer
Masahiko Miura, Naoto Maeda and Yoshikazu Murawaki
Division of Medicine and Clinical Science, Department of Multidisciplinary Internal Medicine, 
School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504 Japan
The highly polymorphic HRAS1 variable number of tandem repeats (VNTR) has been 
described as an inherited predisposing factor in various human cancers.  The aim of the 
present study was to evaluate the association between the presence of rare HRAS1 VNTR 
alleles and colorectal adenoma and cancer.  A total of 165 Japanese patients underwent 
total colonoscopy with informed consent, and were divided into 2 groups: colorectal 
neoplastic and non-neoplastic patients.  Two hundred and sixteen HRAS1 VNTR alleles 
from 108 colorectal neoplastic patients (67 adenomas and 41 cancers) and 114 alleles 
from 57 non-neoplastic patients were genotyped using PCR-based long-agarose gel elec-
trophoresis assay of peripheral blood leukocyte DNA.  Rare alleles were differentiated 
from 4 types of common allele (a1, a2, a3 and a4) by shifts in electrophoretic mobility. 
The prevalence of rare HRAS1 VNTR alleles was higher in colorectal neoplastic patients 
than in non-neoplastic patients (25.4% and 34.1% versus 8.8%).  The adjusted odds ra-
tio with at least one rare allele was 8.65 (95% conﬁdence interval = 2.93–25.53, P < 0.0001) 
in colorectal neoplastic patients.  The presence of rare HRAS1 VNTR alleles could be a 
genetic predisposing factor for risk of colorectal neoplasm in Japanese people.
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Recently, the rate of colorectal cancer has been 
rapidly increasing in Japan, and colorectal cancer 
is now the main cause of death from malignant 
disease as in many other countries (Yoshimi and 
Sobue, 2004).  In fact, age-standardized incident 
rates are similar to rates in US populations of 
Caucasians (Yiu et al., 2004).  The reason has 
generally been ascribed to the westernized diet, 
characterized by a high intake of fat and meat es-
pecially after World War II (Kono, 2004), where-
as the relevance of genetic predispositions has not 
been sufﬁciently analyzed.
 Colorectal cancer is a multifactorial disease, 
with dietary factors, lifestyle habits and genetic 
predispositions contributing to its development. 
The multifarious molecular changes in cancer 
development frequently involve alterations on 
minisatellites or variable number of tandem re-
peats (VNTR) as well as allelic deletions or loss 
of heterozygosity.  Since the HRAS1 VNTR allelic 
polymorphism in normal individuals and cancer 
patients was surveyed by Krontiris et al. in 1985, 
this polymorphism has been reported to be an 
inherited predisposing factor in various cancers, 
including colorectal, ovarian and lung cancers, 
so far (Krontiris et al., 1993; Lindstedt et al., 
1999; Weitzel et al., 2000).  The proto-oncogene 
HRAS1, located on the short arm of chromosome 
11, encompasses 4 exons ﬂanked by a VNTR re-
gion at the 3' end which consists of a basic 28 bp 
Abbreviations: CI, conﬁdence interval; OR, odds ratio; PCR, polymerase chain reaction; VNTR, variable number of tan-
dem repeats
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consensus sequence.  The HRAS1 VNTR consists 
of four common progenitor alleles, which were 
previously identiﬁed as a1, a2, a3 and a4 having 
repeats of 30, 46, 68 and 84 units, respectively. 
In addition, several rare variants are thought to 
derive from germ-line mutations of the nearest 
common alleles (Kasperczyk et al., 1990).  These 
common alleles represent 94% in Caucasian pop-
ulations (Krontiris et al., 1985).  Minisatellite al-
leles frequently vary not only in the number of re-
peat copies but also in the interspersion pattern of 
the repeat sequence along the VNTR (Conway et 
al., 1996; Ding et al., 1999).  Although the actual 
role of specific HRAS1 VNTR alleles in cancer 
susceptibility is not yet known, it has been shown 
that the HRAS1 VNTR binds at least 4 members 
of the rel NF-κB family of transcriptional regula-
tory factors, suggesting that the VNTR could af-
fect cancer susceptibility by transcriptional modu-
lation of HRAS1 or other nearby genes (Trepicchio 
and Krontiris, 1992; Green and Krontiris, 1993; 
Mukhopadhyay et al., 1995).  The aim of the pres-
ent study is to examine whether Japanese indi-
viduals with rare HRAS1 VNTR alleles are at an 
increased risk for developing colorectal neoplasm.
Materials and Methods
Subjects
A total of 165 Japanese subjects (78 women and 
87 men; age range, 19–90 years; median, 67 
years) were studied between August 2003 and 
March 2005.  All of the subjects had undergone 
total colonoscopy just before the enrollment.  For 
extraction of DNA, 5 mL of peripheral blood 
was obtained from each of the 108 patients with 
histologically conﬁrmed colorectal neoplasm (41 
cancers and 67 adenomas) and 57 non-neoplasm 
(neoplasm-free) subjects.  Subjects were inter-
viewed for medical history, family history of neo-
plastic disease and health habits such as alcohol 
intake and cigarette smoking.  Before enrollment 
and blood sampling, written informed consent 
was obtained from all patients and non-neoplasm 
subjects.  This study was approved by the Institu-
tional Review Boards of Tottori University Fac-
ulty of Medicine (approval number: G 16).
HRAS1 VNTR genotyping
Genomic DNA was extracted from peripheral 
blood samples using DnaQuick II DNA extraction 
kits (Dainippon Pharmaceutical, Osaka, Japan) 
as recommended by the supplier.  Using the ex-
tracted DNA as a template, the HRAS1 VNTR re-
gion was ampliﬁed by polymerase chain reaction 
(PCR) using a commercially available kit, Expand 
High Fidelity PCR System (Roche Diagnostics, 
Mannheim, Germany), according to the manufac-
turer's instructions.  The sequences of the primers 
were: the forward primer, 5'-ATC TAC AGT CCC 
CCT TGC CG -3'; the reverse primer, 5'-GCA 
ACT GAC CGT GCA AGT CA -3'.  Reactions 
were carried out using the following conditions: 2 
min at 95°C and then ampliﬁed for 10 cycles con-
sisting of 15 s at 94°C, 30 s at 62°C and 2 min at 
72°C, followed by 20 cycles of 15 s at 94°C, 30 s 
at 62°C and 2 min plus cycle elongation of 5 s for 
each cycle at 72°C.  A ﬁnal extension step at 72°
C for 7 min was added to terminate the ampliﬁca-
tion.
 Subsequently, the PCR product was elec-
trophoresed on a 1% agarose gel 30 cm in length 
using TBE buffer (45 mM Tris-borate, pH 8.3 
and 2 mM EDTA) to conﬁrm the size.  Molecular 
size marker IV (Nippon Gene, Tokyo, Japan) and 
a 100 bp ladder marker (Bio-Rad Lab., Hercules, 
CA) were loaded in approximately every 7th and 
8th lane on all gels to minimize artifacts due to 
gel distortion.  Gels were stained with ethidium 
bromide and destained in water to allow direct 
visualization of the alleles (Fig. 1).  The 4 most 
common HRAS1 VNTR alleles were labeled a1, 
a2, a3 and a4.  The other alleles were labeled in 
terms of the difference in number of 28 bp repeat 
units from that of “the common allele” closest in 
size.  For example, “a1+” refers to the allele with 
28 bp repeat unit more than a1, “a1-” refers to the 
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allele with 28 bp repeat unit less than a1; these are 
referred to as “rare alleles”.
Statistical analysis
As in other published studies, alleles were catego-
rized into two sets: common and rare.  The as-
sociation between rare HRAS1 VNTR alleles and 
colorectal neoplasm was assessed by comparing 
the proportions of patients and non-neoplasm sub-
jects with one or more rare alleles.  The statistical 
signiﬁcance of the different means or proportions 
was measured using analysis of variance or chi-
square test.  To evaluate increased risk of colorec-
tal neoplasm associated with the presence of rare 
HRAS1 alleles, odds ratios (ORs) and 95% conﬁ-
dence intervals (CIs) were computed and adjusted 
by logistic regression for several covariates poten-
tially associated with neoplastic risk such as age, 
sex, family history of neoplasm, alcohol intake 
and smoking status.  The statistical analyses were 
performed using the software package SPSS II for 
Windows (version 11.0 J, SPSS Japan, Tokyo).
Results
Characteristics of research subjects
The characteristics of participants are summa-
rized in Table 1.  Adenoma cases were more likely 
than non-neoplasm cases to be male and to have 
a family history (all of malignancy), and cancer 
cases were more likely to be older and to smoke 
habitually.  No differences between neoplastic and 
non-neoplastic cases were observed in other clini-
copathological variables.
HRAS1 VNTR allelic patterns
The HRAS1 VNTR allelic patterns are shown in 
Table 2.  We genotyped 216 HRAS1 VNTR alleles 
from 108 patients with colorectal neoplasm (41 
cancers and 67 adenomas) and 114 alleles from 57 
non-neoplasm subjects.  Regarding the distribu-
tion of common alleles in our study, most subjects 
had a1 alleles, and none had a3 or a4 alleles.
Fig. 1.  Representative examples of the HRAS1 VNTR allele.  Rare alleles are indicated by the addition (+) or deletion 
(–) of 28 bp motifs from common alleles.  Lanes M4 and L: molecular weight standards.
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Association between HRAS1 VNTR and 
colorectal neoplasm
To evaluate increased risk of colorectal neoplasm 
associated with the presence of rare HRAS1 al-
leles, odds ratios (ORs) and 95% CIs were com-
puted and adjusted by logistic regression for 
several covariates potentially associated with 
neoplastic risk such as age, sex, family history 
of neoplasm, alcohol intake and smoking status 
(Table 3).  The adjusted OR for colorectal neo-
plasm was 8.65 (95% CI = 2.93–25.53, P < 0.0001). 
Repeating the analyses among cancer cases only, 
Table 1.  Characteristics of research subjects
Variables Non-neoplasm [57]  Colorectal neoplasm
 Adenoma [67] P† Cancer [41] P†
 Number (%) Number (%)  Number (%) 
Age (year) 60.6 ± 16.6  65.4 ± 9.4  0.11 68.4 ± 10.9  0.01
Sex (male/female) 23/34  41/26  0.02 23/18  0.12
Family history
    All of malignancies 18/50 (36.0) 32/53 (60.4) 0.01 19/41 (46.3) 0.32
    Only colorectal cancer  7/50 (14.0)  3/53 (  5.7) 0.15  8/41 (19.5) 0.48
Alcohol*(60 mg/day)  9/53 (17.0) 12/53 (22.6) 0.46  7/41 (17.1) 0.99
Smoking*(habitually) 15/52 (28.8) 22/53 (41.5) 0.17 21/41 (51.2) 0.03
 Continuous variables expressed as mean ± SD. 
   [   ], number of subjects.  
* Assessed only in available patients. 
† P values were calculated versus non-neoplasm. Statistical signiﬁcance was deﬁned as P < 0.05. 
the OR was 13.16 (95% CI = 3.69–47.00, P < 
0.0001).  The OR in adenoma was calculated at 
6.59 (95% CI = 2.07–21.02, P < 0.001).
Discussion
 
In addition to many environmental factors, ge-
netic polymorphisms are thought to inﬂuence the 
carcinogenesis of colorectal cancer.  Although 
there have been many candidate genes associ-
ated with colorectal carcinogenesis, only 2 genes, 
HRAS1 VNTR and APC-1 1307K, were found 
Table 2.  HRAS1 VNTR allelic patterns 
 Non-neoplasm Colorectal neoplasm
   Adenoma Cancer
 Number (%) Number (%) Number (%)
Common alleles  a1 103 (90.3) 100 (74.6) 54 (65.9)
 a2 1 (0.9) 0 (0) 0 (0)
 a3 0 (0) 0 (0) 0 (0)
 a4 0 (0) 0 (0) 0 (0)
                               Subtotal 104 (91.2) 100 (74.6) 54 (65.9)
Rare alleles       ~a1- 9 (7.9) 19 (14.2) 17 (20.7)
 a1+~a2- 1 (0.9) 15 (11.2) 11 (13.4)
 a2+~a3- 0 (0) 0 (0) 0 (0)
 a3+~a4- 0 (0) 0 (0) 0 (0)
 a4+~ 0 (0) 0 (0) 0 (0)
                               Subtotal 10 (8.8) 34 (25.4) 28 (34.1)
Total  114   134  82
 [57 individuals] [67 individuals] [41 individuals] 
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Table 3. Association between HRAS1 VNTR and colorectal neoplasm
    Genotypes  Non-neoplasm [57] Neoplasm [108] Type of tumor
    Adenoma [67] Cancer [41]
Common/common 50 60 42 18
Common/rare or rare/rare 7 48 25 23
Odds ratio   1.00 8.65  6.59  13.16 
95% conﬁdence interval 2.93–25.53 2.07–21.02 3.69–47.00
P  Not signiﬁcant < 0.0001 < 0.001 < 0.0001
[  ], number of subjects. 
P: less than 0.05 is signiﬁcant.
to have a polymorphism that increases colorec-
tal carcinogenesis in meta-analysis reported by 
Houlston and Tomlinson (2001).  De Jong et al. 
(2002) reviewed 20 genes (30 gene polymor-
phisms) discussed in several reports, and specu-
lated that HRAS1 VNTR, GSTT1, NAT2 (pheno-
type), ALDH2 and TNF-α (α2 allele) increase 
carcinogenetic risk.  They summarized that 
HRAS1 VNTR was involved in colon carcinogen-
esis with an OR of 2.50 to 2.67.  However, these 
studies of the association between HRAS1 VNTR 
polymorphisms and colorectal cancer were per-
formed on Caucasians, while there has been no 
study performed on Japanese.  Racial differences 
in the HRAS1 VNTR allele distribution have been 
reported (Weston et al., 1991).  In our subjects, 
the most common alleles were a1, and no larger 
alleles (a3 and a4 alleles) were noted.  In a previ-
ously reported HRAS1 VNTR allele distribution 
in Japanese people (Ishikawa et al., 1987; Honda 
et al., 1988; Pierce et al., 2000), a1 accounted for 
a high ratio, and the frequencies of a2, a3 and a4 
alleles were less than 10% in each allele.  The ab-
sence of a3 and a4 in our study suggests the pres-
ence of regional differences, in addition to racial 
differences, but the details are not clear because 
of the small number of patients.
 In this study, in agreement with previous re-
ports on Caucasians (Klingel et al., 1991; Kronti-
ris et al., 1993; Gosse-Brun et al., 1998; Vega et 
al., 2001), the frequency of the rare alleles was 
significantly higher in the neoplasm group and 
the adjusted OR of colorectal neoplasm with at 
least one rare allele was 8.65 (P < 0.0001), show-
ing the close association of HRAS1 VNTR poly-
morphisms with colorectal neoplasms in Japa-
nese.  Furthermore, the adjusted OR of colorectal 
cancer was markedly higher.  The recent increase 
in colorectal cancer patients in Japanese may be 
due to additional external factors such as post-war 
dietary changes in individuals with genetic pre-
dispositions. 
 This is the ﬁrst report to clarify the signiﬁ-
cant relationship of HRAS1 VNTR and colorectal 
adenoma.  Previous studies reported only some 
comparison with colorectal cancer, and did not 
discuss adenoma.  Generally, neoplasms develop 
in the adenoma-carcinoma sequence (Vogelstein 
et al., 1988) in most colorectal cancers.  It has 
been suggested that HRAS1 VNTR polymor-
phisms are involved in the early stage of tumori-
genesis as a genetic predisposing factor.
 We also found the difference in OR between 
adenoma (OR; 6.59) and cancer (OR; 13.16) pa-
tients.  Although the reason for the increase in OR 
in colorectal cancer patients is not clear, many 
hereditary predispositions may be involved in the 
carcinogenesis in a complex manner.
 Since Krontiris et al. (1985) reported on the 
association of HRAS1 VNTR with carcinogenesis, 
other associations with various other cancers be-
sides colorectal cancer have been reported mainly 
in Europe and America.  However, some reports 
presented negative views of a causal relationship 
in recent cases of breast cancer and urinary blad-
der cancer (Firgaira et al., 1999; van Gils et al., 
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2002; Tamimi  et al., 2003).  This may have been 
due to advances in molecular-biological tech-
niques that have allowed the resolution of single-
repeat differences (particularly in larger sizes), 
leading to a more precise classification of com-
mon and rare alleles than classiﬁcation by South-
ern blot.  In recent reports of colorectal cancer 
using the PCR method (Vogelstein et al., 1988; 
Vega et al., 2001), a significant correlation was 
noted between HRAS1 VNTR and colorectal can-
cer.  In this study, we also used the PCR method, 
and found significant differences between non-
neoplasm and neoplasm patients.
 In conclusion, there is a strong association 
between rare alleles of the HRAS1 VNTR and 
colorectal neoplasm in Japan.  If these results are 
conﬁrmed, then from the standpoint of preventive 
medicine, HRAS1 VNTR polymorphisms may 
be useful in identifying risk groups for colorectal 
neoplasms.  Further investigation of differences 
in HRAS1 VNTR polymorphisms in development 
sites, histologic types, and prognosis of colon can-
cer may be necessary.
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